Tetracycline

Tetracycline is a ribosome-targeting antibiotic that inhibits bacterial growth by interfering with protein synthesis, making translation control its core biological function[1]. Mechanistically, tetracyclines interact with the ribosome and inhibit translation, while structural studies show that resistance proteins protect the 70S ribosome from tetracycline binding[2][3]. In bacterial disease and resistance models, tetracycline resistance occurs mainly through energy-dependent efflux, ribosomal protection, target mutation, drug modification, or rare enzymatic inactivation[1][4][5]. Compared with related tetracycline-family compounds, including doxycycline, minocycline, and tigecycline, tetracycline shares ribosomal binding and translation inhibition, but resistance determinants can differ in host range and genetic mobility[1][4][5]. Tet(O) and Tet(M) are key ribosomal protection proteins, and Tet(O) resembles elongation factor EF-G while using domain-specific ribosome contacts to mediate resistance[3][6]. For experimental applications, tetracycline remains useful for studying antibiotic uptake, ribosomal inhibition, efflux pumps, mobile resistance genes, and environmental selection of resistant bacteria[4][5].